Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-024-03918-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Natalia Szóstak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland. nszostak@ibch.poznan.pl. Hauptthemen laut MEDLINE: Melanoma, Gastrointestinal Microbiome, Lymphocytes, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Narodowe Centrum Badań i Rozwoju.
Abstract (Originalsprache)
Research has shown that the microbiome can influence how the immune system responds to melanoma cells, affecting the course of the disease and the outcome of the therapy. Here, we used the metagenomic approach and flow cytometry analyses of blood cells to discover correlations between gut fungi of metastatic melanoma patients enrolled in anti-PD-1 therapy and lymphocytes in their blood. We analyzed the patterns of associations before the first administration of anti-PD-1 therapy (BT, n = 61) and in the third month of the therapy (T3, n = 37), allowing us to track changes during treatment. To understand the possible impact of gut fungi on the efficacy of anti-PD-1 therapy, we analyzed the associations in clinical beneficiaries (CB, n = 37) and non-beneficiaries (NB, n = 24), as well as responders (R, n = 28) and non-responders (NR, n = 33). Patients with LDH < 338 units/L, overall survival (OS) > 12, CB, as well as R, had lower levels of Shannon diversity ( p = 0.02, p = 0.05, p = 0.05, and p = 0.03, respectively). We found that the correlation pattern between intestinal fungi and lymphocytes was specific to the type of response, positive or negative. When comparing CB and NB groups, correlations with opposite directions were detected for C. albicans , suggesting a response-specific immune reaction. For CB, M. restricta exhibited a set of correlations with different types of lymphocytes, with prevalent positive correlations, suggesting a robust immune response in the CB group. This result extends our former research, where M. restricta and C. albicans were associated with an increased risk of melanoma progression and a poorer response to anti-PD-1 treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland. nszostak@ibch.poznan.pl.
- Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
- Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland.
- Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866, Poznan, Poland.
- Department of Food Biotechnology and Microbiology, Poznan University of Life Sciences, Poznan, Poland.
- Department of Medical and Experimental Oncology, Institute of Oncology, Poznan University of Medical Sciences, Poznan, Poland.
Förderung
- Narodowe Centrum Nauki
- Narodowe Centrum Badań i Rozwoju
Zitieren
APA
Szóstak, N., Budnik, M., Tomela, K., Handschuh, L., Samelak-Czajka, A., Pietrzak, B., Schmidt, M., Kaczmarek, M., Galus, Ł., Mackiewicz, J., Mackiewicz, A., Kozlowski, P., & Philips, A. (2025). Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03918-9
Vancouver
Szóstak N, Budnik M, Tomela K, Handschuh L, Samelak-Czajka A, Pietrzak B, et al. Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-024-03918-9
BibTeX
@article{Szstak2025,
author = {Szóstak, Natalia and Budnik, Michał and Tomela, Katarzyna and Handschuh, Luiza and Samelak-Czajka, Anna and Pietrzak, Bernadeta and Schmidt, Marcin and Kaczmarek, Mariusz and Galus, Łukasz and Mackiewicz, Jacek and Mackiewicz, Andrzej and Kozlowski, Piotr and Philips, Anna},
title = {Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-024-03918-9}
}
EUVIMED